Article | August 22, 2017

Using eCOA For The First Time

Source: ERT

By Dascha Turner, LIC.PHIL.I, Clinical Psychologist

Using eCOA For The First Time

The importance of patient-reported outcomes (PRO) is evidenced by their increased use in clinical trials and in drug and device label claims. In many cases, the best way to measure symptoms and functional status is through insights provided by the patient, but few people know how to go about integrating ePRO into their clinical trials. Download this white paper to learn about a completed a Phase 2 clinical trial that used electronic PRO for the first time and identified the key decision points, responsibilities and lessons learned for incorporating ePRO into clinical trial practices.